Effect of Chromium-Enriched Yeast on Fasting Plasma Glucose, Glycated Haemoglobin and Serum Lipid Levels in Patients with Type 2 Diabetes Mellitus Treated with Insulin

Abstrakt

Two-week chromium supplementation led to decrease of fasting plasma glucose and glycated hemoglobin levels in patients with type 1 diabetes mellitus, most probably due to improvement of insulin sensitivity.

Klíčová slova

• Chromium
• Diabetes mellitus (DM2)
• Glycated haemoglobin (HbA1c)
• Fasting plasma glucose (FPG)
• Insulin resistance
• Serum lipids